Kristen N. Ganjoo
Cancer Prevention Institute of California(US)Stanford Medicine(US)Stanford Cancer InstituteStanford University(US)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Tuberous Sclerosis Complex Research, Vascular Tumors and Angiosarcomas, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics
Most-Cited Works
- → NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors(2010)1,215 cited
- → Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology(2022)1,120 cited
- → Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial(2015)817 cited
- → Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology(2018)724 cited
- → Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial(2019)463 cited
- → R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study